BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22921974)

  • 21. New evidence on old drugs; warfarin versus aspirin after bioprosthetic aortic valve placement.
    Stevens SM; Doty JR
    Thromb Res; 2017 Feb; 150():102-103. PubMed ID: 28012566
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral anticoagulation is not necessary for patients with bioprosthetic mitral valve replacement in atrial fibrillation.
    Nuñez L; Pinto AG; Larrea JL; Gil Aguado M; Connor FO
    Z Kardiol; 1986; 75 Suppl 2():321-5. PubMed ID: 3727711
    [No Abstract]   [Full Text] [Related]  

  • 23. Coronary embolism due to probable clinical bioprosthetic aortic valve thrombosis: a case report.
    Ananda RA; Zhang Z
    BMC Cardiovasc Disord; 2023 Jun; 23(1):324. PubMed ID: 37365533
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparing warfarin with aspirin after biological aortic valve replacement: a prospective study.
    Gherli T; Colli A; Fragnito C; Nicolini F; Borrello B; Saccani S; D'Amico R; Beghi C
    Circulation; 2004 Aug; 110(5):496-500. PubMed ID: 15289387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin or Coumadin as the drug of choice for valve replacement with porcine bioprosthesis.
    Nuñez L; Aguado MG; Celemín D; Iglesias A; Larrea JL
    Ann Thorac Surg; 1982 Apr; 33(4):354-8. PubMed ID: 7073379
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of anticoagulation regimens after Carpentier-Edwards aortic or mitral valve replacement.
    Blair KL; Hatton AC; White WD; Smith LR; Lowe JE; Wolfe WG; Young WG; Oldham HN; Douglas JM; Glower DD
    Circulation; 1994 Nov; 90(5 Pt 2):II214-9. PubMed ID: 7955256
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors.
    Brueck M; Kramer W; Vogt P; Steinert N; Roth P; Görlach G; Schönburg M; Heidt MC
    Eur J Cardiothorac Surg; 2007 Jul; 32(1):108-12. PubMed ID: 17449264
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of anticoagulant therapy in cloth-covered prosthetic valves.
    Isom OW; Williams CD; Falk EA; Spencer FC; Glassman E
    Circulation; 1973 Jul; 48(1 Suppl):III48-50. PubMed ID: 4721281
    [No Abstract]   [Full Text] [Related]  

  • 29. Prevention of thromboembolism using aspirin after mitral valve replacement with porcine bioprosthesis.
    Nuñez L; Gil Aguado M; Larrea JL; Celemín D; Oliver J
    Ann Thorac Surg; 1984 Jan; 37(1):84-7. PubMed ID: 6691742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thromboembolism in patients with aortic porcine bioprostheses.
    David TE; Ho WI; Christakis GT
    Ann Thorac Surg; 1985 Sep; 40(3):229-33. PubMed ID: 4037914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Valvular Heart Disease in Adults: Management of Prosthetic Heart Valves.
    Trujillo JF; Hollenberg SM
    FP Essent; 2017 Jun; 457():23-29. PubMed ID: 28671806
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulation after bioprosthetic aortic valve replacement.
    Nowell J; Jahangiri M
    J Thorac Cardiovasc Surg; 2010 Nov; 140(5):1201-2; author reply 1202. PubMed ID: 20951265
    [No Abstract]   [Full Text] [Related]  

  • 33. Sudden cardiac arrest during emergency caesarean delivery in a 31-year-old woman, due to accelerated structural valve degeneration of an aortic valve bioprosthesis.
    O'Sullivan CJ; Bühlmann Lerjen E; Pellegrini D; Eberli FR
    BMJ Case Rep; 2015 Nov; 2015():. PubMed ID: 26568057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of aspirin use in the incidence of thromboembolic events after bioprosthesis replacement in patients with rheumatic disease.
    Durães AR; Durães MA; Correia LC; Fernandes AM; Aras Junior R
    Rev Bras Cir Cardiovasc; 2013; 28(3):347-52. PubMed ID: 24343684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and Use of Anticoagulation After Aortic Valve Replacement With Bioprostheses: A Meta-Analysis.
    Riaz H; Alansari SA; Khan MS; Riaz T; Raza S; Luni FK; Khan AR; Riaz IB; Krasuski RA
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):294-302. PubMed ID: 27166205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An audit of anticoagulation practice among UK cardiothoracic consultant surgeons following valve replacement/repair.
    Vaughan P; Waterworth PD
    J Heart Valve Dis; 2005 Sep; 14(5):576-82. PubMed ID: 16245494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cerebral microembolization after bioprosthetic aortic valve replacement: comparison of warfarin plus aspirin versus aspirin only.
    Al-Atassi T; Lam K; Forgie M; Boodhwani M; Rubens F; Hendry P; Masters R; Goldstein W; Bedard P; Mesana T; Ruel M
    Circulation; 2012 Sep; 126(11 Suppl 1):S239-44. PubMed ID: 22965989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioprosthetic aortic valve thrombosis under effective direct oral anticoagulant therapy.
    Guler A; Erata YE; Aydin S; Gunes HM; Babur Guler G
    Echocardiography; 2023 Sep; 40(9):983-988. PubMed ID: 37363827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early postoperative thrombosis of an aortic bioprosthetic valve: should anticoagulation be patient specific?
    Efthymiou CA; Mills RJ; O'Regan DJ
    J Card Surg; 2013 Nov; 28(6):723-9. PubMed ID: 23992398
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolated aortic valve replacement with the Björk-Shiley tilting disc prosthesis and the porcine bioprosthesis.
    Egloff L; Rothlin M; Turina M; Senning A
    Eur Heart J; 1980 Apr; 1(2):123-7. PubMed ID: 7285970
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.